TITLE

Revealed: The costly cancer drugs that DON'T extend lives

AUTHOR(S)
Ben Spencer
PUB. DATE
October 2017
SOURCE
Daily Mail;10/5/2017, p4
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
MOST cancer drugs given a European medical licence do nothing to extend or improve the lives of patients, a study has concluded.
ACCESSION #
125466934

 

Related Articles

  • THEY PUT A PRICE ON MY LIFE, SAYS DYING MOTHER. Victoria Allen // Daily Mail;10/14/2014, p1 

    BREAST cancer patients were 'devastated' yesterday after a drug that could extend their lives by six months was rejected by a medical watchdog.

  • Cancer drug is 'too expensive'.  // Daily Mail;7/7/2014, p16 

    A DRUG that could prolong the lives of breast cancer sufferers has been deemed 'not cost effective' by a national drug watchdog.

  • The rejected drug that could extend life.  // Daily Mail;11/3/2014, p25 

    A BREAST cancer drug rejected by an NHS rationing body can extend survival times by five months, a study has revealed.

  • RESEARCH & TECHNOLOGY.  // MondayMorning;8/2/2010, Vol. 18 Issue 29, p4 

    The article presents news brief related to the drug industry. Allos Therapeutics Inc. reports that its lung-cancer drug Folotyn increased survival of patients, however, the lower sales raised concern about the marketing opportunity. A study revealed that prostate cancer vaccine Provenge...

  • Beta blockers could give ovarian cancer victims extra 4 years. Ben Spencer // Daily Mail;8/24/2015, p31 

    TAKING beta blockers could extend the lives of women with ovarian cancer by up to four years, scientists reveal today.

  • We must put a higher value on our lives. Kirwan, Nick // Mortgage Strategy;9/4/2006, p45 

    The article informs that the National Institute for Health and Clinical Excellence (NICE) has decided not to fund the cost of bowel cancer drugs viz Avastin and Erbitrux. As per NICE's directive, the drugs are not cost-effective and also it has a finite amount of money available. Great Britain...

  • Breast cancer drug gives an extra six months of life and stops loss of hair. Jenny Hope // Daily Mail;10/2/2012, p8 

    A NEW 'smart' drug for breast cancer extends women's lives by six months while reducing toxic side effects including hair loss.

  • New treatment boosts life expectancy.  // Daily Mail;9/29/2014, p19 

    A NEW breast cancer drug can extend patients' lives by an extra year and four months on average compared to standard treatment, researchers say.

  • Food and drugs: Administer together.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p848 

    The article reports on a study which reveals the need to study the consumption of cancer drugs with food for safety and cost-effective purposes.

  • RECORD DELAYS FOR NHS CANCER TREATMENT ARE COSTING LIVES. Eleanor Hayward // Daily Mail;6/12/2019, p16 

    CANCER waiting times are stuck in a 'downward spiral' and are costing lives, a damning report reveals today.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics